Cargando…
Hepatic Fibrosis and Steatosis in Metabolic Syndrome
BACKGROUND: Metabolic syndrome (MetS) is a group of factors associated with increased risks of cardiovascular disease and overall mortality. Nonalcoholic fatty liver disease (NAFLD) is a common disorder that has been shown to cause hepatic steatosis and fibrosis. The relationship between NAFLD and M...
Autores principales: | Gangireddy, Venu Gopala Reddy, Pilkerton, Courtney, Xiang, Jun, Tinajero, Ruben, Ashcraft, Amie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for the Study of Obesity
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987451/ https://www.ncbi.nlm.nih.gov/pubmed/35283365 http://dx.doi.org/10.7570/jomes21062 |
Ejemplares similares
-
Seronegative immunity to SARS-CoV-2: a case study
por: Miller, Kyle D., et al.
Publicado: (2022) -
Palliative Opioids May Be a Bridge to Care for Rural Long-Term Care Facility Residents with Severe COVID-19 Symptoms
por: Crocetti, Emily, et al.
Publicado: (2021) -
Rural Appalachian Women Will Suffer Disproportionately if Attempts to Further Restrict Emergency Contraception are Successful
por: Ashcraft, Amie M., et al.
Publicado: (2023) -
Clinical Frailty Assessment and Associated Outcomes Through COVID-19 Outbreak in a Long-Term Care Facility
por: Assadzandi, Shauna, et al.
Publicado: (2022) -
Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018)